Canon Inc.
Notice of Execution of Merger Agreement for Merger with Canon Electron Tube Devices Co., Ltd. (Simple Absorption-Type Merger)
Canon has resolved and executed an agreement for a simple absorption-type merger involving its 100% subsidiary CETD. The scheduled effective date is January 1, 2027. The surviving company will be Canon Inc., and the dissolved company will be Canon Electron Tube Devices Co., Ltd. The integration aims to consolidate the Medical Business Unit's component operations and maximize synergies. Financial impact is expected to be minimal.
Key Figures
- Scheduled effective date of this absorption-type merger: 2027-01-01 (scheduled)
- Method of this absorption-type merger: Canon Inc. as surviving company, CETD as dissolved company
- Capital structure / Major shareholder: CETD is 100% owned (Canon Inc. holds 100%)
AI要約
Overview of the Absorption-Type Merger
At today's Board meeting, Canon Inc. resolved to carry out a simple absorption-type merger with Canon Inc. as the surviving company and Canon Electron Tube Devices Co., Ltd. as the dissolved company, and executed the agreement with an effective date of January 1, 2027. No allotment will be made, and it is noted that CETD has not issued any stock acquisition rights.
Outlook and Impact
This absorption-type merger involves the Company and its wholly owned subsidiary, and the impact on consolidated results is expected to be minor. By integrating the Medical Business Unit's component operations, the aim is to unify the foundations for development, production, sales and administration to enhance synergies and cost competitiveness, accelerating profitability and growth.
Canon Inc.
Company overview · Stock price · Financial data · All IR
